Physician profile
Channing Dale Willoughby
NPI 1235336421
$81,592.97
in general payments reported to CMS, 2019-2025
35 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,967 · 2020: $1,488 · 2021: $5,596 · 2022: $18K · 2023: $18K · 2024: $22K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,550 · Travel and Lodging: $5,129 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,510.00 |
| Food and Beverage | $13,881.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,550.00 |
| Travel and Lodging | $5,128.89 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,230.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $45,397.13 | 2021-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $13,105.85 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $6,688.55 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Nevro Corp. | $4,168.32 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $3,294.30 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic USA, INC. | $3,254.78 | 2019-2020 | |
| Boston Scientific Corporation | $1,137.44 | 2019-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $900.51 | 2021-2024 | Ha Minuteman G3-R |
| Mml US, INC. | $614.37 | 2022 | |
| Globus Medical, INC. | $560.43 | 2025 | Senza |
| Spr Therapeutics, INC | $552.69 | 2020-2021 | |
| Vertos Medical, INC. | $270.27 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $265.08 | 2019-2024 | Relistor |
| Relievant Medsystems, INC. | $259.20 | 2021-2023 | Intracept |
| Avanos Medical | $216.81 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $190.38 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $112.98 | 2020-2021 | |
| Ge Healthcare | $72.73 | 2020 | |
| Allergan, INC. | $71.49 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $70.51 | 2022 | |
| Collegium Pharmaceutical, INC. | $55.19 | 2021-2022 | |
| Stryker Corporation | $52.80 | 2022-2023 | Gamma |
| Inari Medical, INC. | $40.92 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scilex Pharmaceuticals INC. | $35.66 | 2020-2021 | |
| Fidia Pharma USA INC. | $27.40 | 2019-2024 | Hym/Hyn |
| Grt US Holding, INC. | $23.21 | 2022 | |
| Flowonix Medical Incorporated | $22.12 | 2019 | |
| Abbvie INC. | $19.86 | 2022 | |
| Neurelis, INC. | $19.46 | 2024 | Valtoco |
| Novartis Pharmaceuticals Corporation | $17.99 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.05 | 2025 | |
| Redhill Biopharma INC. | $15.65 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.12 | 2021 | |
| Orthogenrx INC. | $15.00 | 2019 | |
| Daiichi Sankyo INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Channing Willoughby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.